Consumer genetic tests
This article was originally published in The Tan Sheet
Executive Summary
A July 31 FDA consumer alert advises that at-home genetic tests "may lack scientific validity or provide meaningful results only in the context of a full medical evaluation." The Government Accountability Office recently issued a report evaluating the genetic tests and found some made disease-risk claims and offered dietary advice that "rarely goes beyond standard sensible dietary recommendations" (1"The Tan Sheet" July 31, 2006, p. 9). The Federal Trade Commission also recently reminded consumers that "because of the complexities involved in both the testing and the interpretation of the results, genetic tests should be performed in a specialized laboratory, and the results should be interpreted by a doctor or trained counselor"...
You may also be interested in...
GAO Report, FTC Warn Consumers Of Misleading At-Home Genetic Kits
The validity of at-home genetic tests has come under fire from both the Federal Trade Commission and the Government Accountability Office
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.